Background {#Sec1}
==========

Vitamin D is well known for its importance in calcium and phosphorus homeostasis and bone formation. Recent studies demonstrate that vitamin D may have an important role in modulating the innate and adaptive immune response to infectious pathogens including gram negative and positive bacteria, fungi, and mycobacteria \[[@CR1]\]. Vitamin D deficiency in critically ill patients has been associated with increased risk of infectious complications and mortality \[[@CR2]--[@CR8]\] as it is an integral component to the production of cathelicidin and other antimicrobial proteins produced by macrophages and neutrophils \[[@CR9]\]. The synthesis of these antimicrobial proteins is highly expressed at integumentary barrier sites such as the respiratory epithelium \[[@CR9]\].

Unfortunately, data regarding vitamin D depletion in critically ill patients with severe multiple traumatic injuries are limited due to studies that have incorporated these patients as part of a larger population \[[@CR10], [@CR11]\], evaluated patients months after the acute phase of their injury \[[@CR12], [@CR13]\], or evaluated non-critically ill patients post injury \[[@CR14], [@CR15]\]. Since infections, especially epithelial barrier site infections such as pneumonia, are common complications leading to death in approximately 20 % of critically ill trauma patients \[[@CR16]\], it would be important to ascertain if vitamin D deficiency is prevalent in this population. The intent of this study was to ascertain the incidence and risk factors for the development of vitamin D deficiency among critically ill trauma patients who required enteral or parenteral nutrition therapy and who were anticipated to have a prolonged intensive care unit (ICU) stay.

Methods {#Sec2}
=======

Design and patient selection {#Sec3}
----------------------------

Adult patients, at least 18 years of age, with severe traumatic injuries and admitted to the ICU of the Presley Trauma Center at Regional One Health in Memphis, Tennessee, and referred to the Nutrition Support Service (NSS) for enteral nutrition (EN) or parenteral nutrition (PN) were eligible for study inclusion. The center is designated as a level 1 trauma center and serves the mid-south region of the USA (western Tennessee, northern Mississippi, Arkansas). Patients had a serum 25-hydroxy vitamin D (25-OH vitamin D) determination while in the ICU following patient referral to the NSS as part of their routine metabolic assessment. Patients excluded from study entry were those known to receive vitamin D beyond a daily multivitamin supplement or those who received chronic glucocorticoids, HIV medications \[[@CR17]\], or other medications known to increase vitamin D catabolism \[[@CR18], [@CR19]\] prior to hospital admission. Females who were pregnant were also excluded.

Study candidates were identified from the Nutrition Support Service monitoring records from June 2013 to June 2014. Winter was defined as November through March based on the presence of reduced skin exposure to ultraviolet light \[[@CR11], [@CR20]\]. Patients' electronic medical record and nutrition support service record were retrospectively reviewed for data retrieval. Injury severity score \[[@CR21]\] (ISS) was scored by trained nurses according to the American Association for the Surgery of Trauma scales for anatomic injury severity and recorded within the data repository of the Tennessee trauma registry at Regional One Health. The study was approved and conducted in accordance with the guidelines established by the University of Tennessee Health Science Center Institutional Review Board and the Regional One Health Office of Medical Research (study reference number 14-02924-XM). Since this was a retrospective, non-interventional study, requirement for written informed consent was waived.

Nutritional regimen and vitamin D intake {#Sec4}
----------------------------------------

Patients were preferentially given enteral nutrition by a nasogastric or orogastric feeding tube whenever possible. Patients were assigned energy and protein goals of 25--32 kcal/kg/d and 2--2.5 g/kg/d per day, respectively \[[@CR22]\]. If the patient's ISS was greater than 20 and enteral access was viable, an enteral formula (1.3 kcal/mL, 78 g protein/L) containing glutamine, arginine, dietary nucleotides, and ω-3 fatty acids was initiated \[[@CR23]\]. Other enteral-fed patients received either a polymeric, high-protein formula (1 kcal/mL, 62 g protein/L or 1 kcal/mL, 93 g protein/L) or a diabetic formula (1.2 kcal/mL, 60 g protein/L). Commercial enteral formulas contained 400--533 IU of vitamin D~3~ per 1000 kcals. Liquid protein supplements were also given per discretion of the NSS \[[@CR22]\]. Patients requiring parenteral nutrition received an individualized prescription to meet target energy and protein goals as a total nutrient admixture via central venous access. Patients who required PN received 200 IU of vitamin D~3~ daily as part of the intravenous multivitamin additive to the PN admixture. Daily EN and PN intakes were recorded for the first fourteen days of nutrition therapy. Pre-resuscitation body weight was used to determine target nutritional goals. Blood glucose concentrations were maintained between 70 and 150 mg/dL with the use of intravenous regular human insulin therapy as previously described \[[@CR24]--[@CR26]\].

Measured variables {#Sec5}
------------------

Serum 25-OH vitamin D concentrations were obtained at 0100 via a venous catheter approximately weekly while the patient remained in the ICU and required PN or EN. Serum 25-OH vitamin D concentrations were assayed by the hospital laboratory via an automated chemiluminescent microparticle immunoassay (Architect System, Abbott Laboratories, Abbott Park, IL, USA). The detection limit was 8 ng/mL (20 nmol/L). Intra-assay and inter-assay coefficient of variations were between 1.4 and 4.6 % for concentrations ranging from 18 to 78 ng/mL (45 to 195 nmol/L) \[[@CR27]\]. Verification studies for accurate concentration determination ranged from 13 to 96 ng/mL (32 to 240 nmol/L) per the manufacturer recommendations \[[@CR28]\]. Other laboratory tests were ordered by the patient's primary service or the NSS and performed by the hospital laboratory as part of the patient's routine clinical care.

Classification of vitamin D insufficiency and deficiency was based on the recommendations of the Institute of Medicine \[[@CR18]\]. A normal 25-OH vitamin D concentration was established as 30 to 80 ng/mL. Patients with a 25-OH vitamin D of 20--29.9 ng/mL were considered vitamin D insufficient whereas those with a 25-OH vitamin D of 13.1--19.9 ng/mL were categorized as deficient and ≤13 ng/mL as severely deficient \[[@CR11], [@CR18]\]. Patients with a serum 25-OH vitamin D concentration determination \<20 ng/mL were prescribed liquid ergocalciferol 50,000 IU once to three times weekly via the feeding tube as previously described \[[@CR29]\]. Patients who received parenteral nutrition did not receive additional liquid enteral vitamin D supplementation beyond intravenous maintenance requirements in the parenteral nutrition solution until enteral access was established \[[@CR29]\]. Only serum 25-OH vitamin D measurements that were obtained prior to enteral liquid vitamin D supplementation were used in this analysis.

Statistical analysis {#Sec6}
--------------------

Data analysis was conducted using SigmaPlot for Windows, version 11.2 (Systat Software, Point Richmond, VA) and SPSS version 22 (IBM Corporation, Chicago, IL). The significance testing and reported probability values (*P*) were two-sided for all variables. A *P* value of ≤0.05 was defined as statistically significant. Continuous data were expressed as mean ± standard deviation. The normality of the distribution of the data was evaluated by the Shapiro-Wilk test. Differences between vitamin D depletion groups for continuous variables were analyzed using one-way analysis of variance with post hoc pair-wise multiple comparisons by the Student-Newman-Keuls test for normally distributed data or Kruskal-Wallis one-way analysis of variance with pair-wise multiple comparison by Dunn's method for non-normally distributed data. Categorical data were evaluated by chi-square analysis. The paired *t* test or Wilcoxon signed rank test was used for comparing two simultaneous 25-OH vitamin D concentrations within the same set of patients. A preliminary bivariate correlation analysis of all collected categorical and quantitative variables for the presence of vitamin D deficiency was conducted to determine which covariates to use in the binary logistic regression analysis. Those variables that achieved a statistically significant trend of *P* ≤ 0.15 were used in the multivariate model. Odds ratio (OR) was expressed as mean with 95 % confidence intervals.

Results {#Sec7}
=======

Patient characteristics {#Sec8}
-----------------------

A total of 158 patients admitted to the trauma ICU were evaluated. The majority of patients were male (82 %), admitted to the hospital due to a motor vehicle collision (62 %), and survived (84 %). Patients exhibited an ISS consistent with severe injury, had a markedly elevated C-reactive protein (CRP) concentration, depressed serum prealbumin concentration, and most were adequate in body weight (body mass index ≥18.5 kg/m^2^). Patients exhibited a mean elevated CRP of 22 mg/dL with a concentration \<10 mg/dL in only 32 patients (20 % of the total population). None of the patients had a normal CRP concentration (\<1 mg/dL). The majority of patients were either Caucasian (47 %) or African-American (41 %) with the remaining patients of either Hispanic or Asian descent. Other patient characteristics among the vitamin D groups are given in Table [1](#Tab1){ref-type="table"}.Table 1Patient characteristicsVariableNormalInsufficientDeficientSeverely deficient*P* ≤25-OH vitamin D concentration range, ng/mL30--8020--29.913.1--19.9≤13*N*6317546Male/female, *n*/*n*5/127/461/1437/90.885Race Caucasian, *n* (%)5 (83 %)22 (71 %)34 (45 %)13 (28 %)0.004 African-American, *n* (%)1 (17 %)5 (16 %)32 (43 %)27 (59 %) Hispanic/other, *n* (%)0 (0 %)4 (13 %)9 (12 %)6 (13 %)Etiology for admission MVA, *n* (%)1 (17 %)21 (68 %)48 (64 %)18 (39 %)0.001 GSW/KSW, *n* (%)0 (0 %)1 (3 %)14 (19 %)19 (41 %) Fall/Assault, *n* (%)5 (83 %)6 (19 %)9 (12 %)6 (13 %) Other, *n* (%)0 (0 %)3 (10 %)4 (5 %)3 (7 %)Age, years60 ± 3046 ± 2245 ± 1843 ± 170.243Weight, kg70 ± 2085 ± 1788 ± 2387 ± 190.206BMI, kg/m^2^22 ± 527 ± 428 ± 729 ± 50.033Injury severity score25 ± 630 ± 1427 ± 1429 ± 130.399C-reactive protein, mg/dL20.4 ± 12.018.5 ± 12.022.1 ± 12.523.7 ± 11.90.380Prealbumin, mg/dL8.9 ± 5.69.9 ± 8.28.7 ± 4.18.5 ± 3.70.989Alcohol abuse, *n* (%)1 (17 %)10 (32 %)17 (23 %)12 (26 %)0.720Admitted Nov--Mar, *n* (%)3 (50 %)10 (32 %)29 (39 %)24 (52 %)0.300Serum ionized calcium, mmol/L1.19 ± 0.061.17 ± 0.061.18 ± 0.091.16 ± 0.070.407Serum phosphorus, mg/dL2.9 ± 0.33.8 ± 0.83.6 ± 1.03.6 ± 1.00.05525-OH vitamin D, ng/mL39.2 ± 7.323.2 ± 3.016.0 ± 2.212.8 ± 0.50.001Hospital day of vitamin D determination, days6.2 ± 2.99.8 ± 5.67.4 ± 5.37.1 ± 4.50.077*BMI* body mass index, *GSW* gunshot wound, *KSW* knife stab wound, *Mar* March, *MVA* motor vehicle accident, *N* number of patients, *Nov* November, *OH* hydroxy\*Significantly different (*P* ≤ 0.05) from the other groups

Prevalence and associated risk factors for vitamin D deficiency {#Sec9}
---------------------------------------------------------------

The vast majority of patients (121, 77 %) were either vitamin D deficient or severely deficient. Forty-six patients (38 % of the total population) exhibited severe deficiency. Only six patients (4 %) had a normal serum 25-OH vitamin D concentration. The remaining 31 patients (19 % of the total population) were vitamin D insufficient. Age, sex, proportion of patients with a history of alcohol or illicit drug abuse, serum prealbumin concentration, or hospital day of the 25-OH vitamin D determination were not statistically different between vitamin D groups (*P* = NS, Table [1](#Tab1){ref-type="table"}). Although there were no differences in body weight among the vitamin D groups, body mass index (BMI) was significantly lower for those with normal vitamin D concentrations compared to the other groups (*P* = 0.033; Table [1](#Tab1){ref-type="table"}).

There was no significant difference in serum 25-OH vitamin D for those who were admitted in the winter season (*n* = 66) versus the other months (*n* = 92): 17.4 ± 7.0 versus 17.4 ± 5.5 ng/mL, respectively (*P* = 0.642). Eighty percent of patients admitted in the winter (53 out of 66) were vitamin D deficient compared to 74 % of patients (68 out of 92) admitted in the remainder of the year (*P* = 0.456). Thirty-six percent of patients (24 out of 66) admitted in the winter were severely vitamin D deficient compared to 24 % of patients (22 out of 92) admitted in the other months of the year (*P* = 0.128).

There were no apparent correlative relationships between serum 25-OH vitamin D concentration and extent of injury as assessed by ISS (*r* = 0.046, *P* = NS, Fig. [1](#Fig1){ref-type="fig"}) or between the amount of inflammation present as evaluated by serum C-reactive protein concentration (*r* = 0.096, *P* = NS; Fig. [2](#Fig2){ref-type="fig"}). A greater proportion of patients with penetrating injuries (gunshot and knife stab wounds) experienced severe vitamin D deficiency (Table [1](#Tab1){ref-type="table"}; *P* = 0.001). Race influenced serum 25-OH vitamin D concentrations as African-Americans had a significantly lower serum 25-OH vitamin D concentration than non-African-Americans (15.4 ± 4.2 versus 18.7 ± 6.9 ng/mL, *P* = 0.001; Fig. [3](#Fig3){ref-type="fig"}) and demonstrated a greater proportion of patients with severe vitamin D deficiency (Table [1](#Tab1){ref-type="table"}; *P* = 0.004). Binomial logistic regression analysis indicated that admitting diagnosis of a gunshot or knife stab wound, African-American race, and increasing body mass index were the most statistically significant covariates associated with vitamin D deficiency (Table [2](#Tab2){ref-type="table"}). Admission diagnosis of a gunshot or knife stab wound was also significantly associated with severe vitamin D deficiency; however, the association with African-American race and body mass index did not achieve statistical significance with severe vitamin D deficiency (Table [2](#Tab2){ref-type="table"}).Fig. 1Relationship between serum 25-OH vitamin D concentration and severity of injury (*r* = 0.046, *P* = 0.571). The insignificant inverse linear relationship was expressed as 25-OH vitamin D concentration = 18.0 − (0.02 × injury severity score) Fig. 2Lack of influence of extent of inflammation as evidenced by C-reactive protein concentration upon serum 25-OH vitamin D concentration (*r* = 0.046, *P* = 0.571). The relationship was described by 25-OH vitamin D concentration = (−0.05 × C-reactive protein concentration) + 18.6 Fig. 3Mean serum 25-OH vitamin D concentration (depicted by the *solid horizontal line*) and range for African-Americans and those of non-African-American race (15.4 ± 4.2 versus 18.7 ± 6.9 ng/mL, respectively, *P* \< 0.001) Table 2Variables associated with vitamin D deficiencyVitamin D deficiency and severe deficiency (25-OH vitamin D \<20 ng/mL) VariableOR*P*  GSW/KSW9.23 (1.13, 75.40)0.038  African-American race4.02 (1.40, 11.58)0.010  Body mass index1.12 (1.03, 1.23)0.010  Serum C-reactive protein1.04 (1.00, 1.08)0.062Severe vitamin D deficiency (serum 25-OH vitamin D ≤13 ng/mL) VariableOR*P*  GSW/KSW3.52 (1.49, 8.23)0.004  African-American race1.88 (0.87, 4.07)0.109*GSW* gunshot wound, *KSW* knife stab wound, *OH* hydroxy, *OR* odds ratio

Serum 25-OH vitamin D concentrations were obtained 7.7 ± 5.1 days following admission to the ICU. No significant correlative relationship was observed between serum 25-OH vitamin D concentration and hospital day for its determination (Fig. [4](#Fig4){ref-type="fig"}; *r* = 0.081, *P* = 0.315). Serum 25-OH vitamin D concentration in those patients whose measurements were done 2 to 4 days post admission to the ICU (mean 2.9 ± 0.9 days post admission, *n* = 47) were not substantially different from those who were measured at least 5 days following admission to the ICU (mean 9.5 ± 5.9 days post admission, *n* = 111): 16.2 ± 4.5 versus 17.9 ± 6.7 ng/mL for each time group, respectively (*P* = 0.231). Ten patients with vitamin D deficiency or severe deficiency who were receiving maintenance vitamin D therapy from their nutritional formula had a second concentration obtained prior to implementation of enteral vitamin D therapy 10.4 ± 4.6 days after the initial determination. Serum concentrations were minimally changed (14.3 ± 1.9 versus 15.4 ± 2.8 ng/mL, respectively, *P* = 0.158). Similar results were observed for 14 patients with vitamin D insufficiency with a repeated determination 8.3 ± 3.5 days following the initial observation (23.2 ± 3.2 versus 24.2 ± 5.8 ng/mL, *P* = 0.401).Fig. 4Influence of intensive care unit (ICU) day upon serum 25-OH vitamin D concentration (*r* = 0.081, *P* = 0.315). The insignificant positive relationship was depicted by 25-OH vitamin D concentration = 16.6 + (0.1 × ICU day)

Clinical outcomes associated with vitamin D deficiency {#Sec10}
------------------------------------------------------

Clinical outcomes of survival, ICU length of stay, hospital length of stay, and proportion of patients that developed a nosocomial infection (e.g., pneumonia, sepsis, wound infection, intra-abdominal abscess, urinary tract infection) while in the ICU were not statistically significant among groups with varying degrees of vitamin D depletion (Table [3](#Tab3){ref-type="table"}). However, a trend towards a shorter ICU length of stay (mean of 14 versus 21 to 23 days for the other groups, respectively; *P* = 0.053) was observed for those patients who had normal vitamin D stores (Table [4](#Tab4){ref-type="table"}). Unfortunately, clinical outcome comparisons between groups (Table [4](#Tab4){ref-type="table"}) were confounded by provision of supplemental vitamin D therapy in patients with vitamin D deficiency which limited interpretation regarding the clinical impact of vitamin D depletion. However, clinical outcomes among the extent of vitamin D depletion groups were not attributed to any differences in calorie, protein, or intrinsic vitamin D intake from the EN or PN (Table [4](#Tab4){ref-type="table"}).Table 3Clinical outcomesVariableNormalInsufficientDeficientSeverely deficient*P* ≤25-OH vitamin D concentration range, ng/mL30--8020--29.913.1--19.9≤13*N*6317546Survived, *n* (%)5 (83 %)27 (87 %)64 (85 %)36 (80 %)0.835ICU length of stay, days14 ± 723 ± 923 ± 1821 ± 160.053Hospital length of stay, days22 ± 1338 ± 2035 ± 2438 ± 220.132Infection, *n* (%)6 (100 %)28 (90 %)54 (72 %)35 (76 %)0.108Hospital day of infection, days6 ± 29 ± 76 ± 58 ± 60.215*ICU* intensive care unit, *N* number of patients, *OH* hydroxy Table 4Vitamin D intake and nutrition therapyVariableNormalInsufficientDeficientSeverely deficient*P* ≤25-OH vitamin D concentration range, ng/mL30--8020--29.913.1--19.9≤13*N*6317546Received supplemental ergocalciferol, *n* (%)0 (0 %)5 (16 %)57 (76 %)35 (76 %)0.001Day ergocalciferol started, days--16 ± 410 ± 711 ± 80.286Ergocalciferol duration, days--27 ± 2415 ± 1320 ± 170.095Caloric intake, kcals/days1060 ± 5241397 ± 4731386 ± 5621420 ± 4120.527Protein intake, g/days109 ± 41114 ± 41106 ± 41108 ± 300.797EN/PN, *n*/*n*6/026/555/2033/130.526Vitamin D from EN/PN, IU/day818 ± 279953 ± 326769 ± 316800 ± 2800.084*EN* enteral nutrition, *N* number of patients, *PN* parenteral nutrition, *OH* hydroxy

Discussion {#Sec11}
==========

Vitamin D depletion has been associated with an increased rate of infections, lengthened hospital stay, and worsened mortality for critically ill patients \[[@CR2]--[@CR8], [@CR30], [@CR31]\]. These worsened outcomes were potentially related to the discovery that the synthesis of 1,25 - dihydroxy \[(OH)~2~\] vitamin D within immune cells derived from circulating 25-OH vitamin D enhances antibacterial activity by triggering production of cathelicidin and other antimicrobial peptides \[[@CR9], [@CR32], [@CR33]\]. Thus, the presence of vitamin D deficiency would result in decreased availability of substrate for 1,25 -(OH)~2~ vitamin D synthesis \[[@CR34]\] and, ultimately, decreased production of antimicrobial peptides. The objective of this study was to ascertain the prevalence and risk factors for vitamin D deficiency for critically ill patients with severe traumatic injuries who are anticipated to have a prolonged ICU length of stay and who require specialized nutrition therapy.

Our data indicated that the majority (77 %) of critically ill patients with traumatic injuries are either deficient or severely deficient with only 4 % of patients having a normal 25-OH vitamin D serum concentration. Our data also indicated that those with penetrating injuries due to a gunshot or knife stab wound, of African-American descent, or an increased body mass index (i.e., obesity) were at greater risk for exhibiting vitamin D deficiency. Our finding regarding the marked and nearly universal prevalence of vitamin D insufficiency or deficiency was important due to the limited amount of data for critically ill patients with severe traumatic injuries \[[@CR10], [@CR11], [@CR35]\].

The etiology for the high incidence of vitamin D deficiency in our population was likely multifactorial. African-Americans have historically been noted to be at risk for vitamin D deficiency due to increased melanin pigment content resulting in a decreased synthesis of pre-vitamin D3 in the skin during exposure to ultraviolet radiation \[[@CR34]\]. Recent data also indicate that serum vitamin D-binding protein concentrations are lower in African-Americans than American Caucasians due to genetic polymorphism differences \[[@CR36]\]. Vitamin D-binding protein accounts for 85 to 90 % of total circulating 25-OH vitamin D with serum albumin binding accounting for an additional 10 to 15 % \[[@CR36]\]. Thus, race-specific vitamin D-binding protein concentrations differences \[[@CR36], [@CR37]\], independent of critical illness, may have also contributed at least in part, for the observed significant decrease in serum 25-OH vitamin D concentration for African-Americans in our trauma patient population.

Since humans obtain 40 to 50 % of their vitamin D requirements from ultraviolet radiation exposure to sunlight \[[@CR38]\], it would be anticipated that the winter months would result in a higher incidence of vitamin D deficiency due to a decrease in outdoor activity as well as a seasonal change in the angle refraction of light from the sun \[[@CR11], [@CR20]\]. Although others suggest a profound 50 % increase in the presence of vitamin D deficiency in critically ill patients when comparing winter month admissions to a late summer month \[[@CR8]\], we found only a modest, statistically insignificant, 16 % and 12 % increase in the incidence of vitamin D deficiency and severe deficiency, respectively. These data suggest other factors outside of pre-hospitalization sunlight exposure may be more important in the pathogenesis of vitamin D deficiency for our critically ill population.

Obesity, in health as well as in critical illness, may also play a role in the development of vitamin D insufficiency and deficiency \[[@CR37], [@CR39]--[@CR41]\]. It has been proposed that decreased 25-OH vitamin D concentrations in obese patients occur due to its sequestration within body fat compartments \[[@CR41]\] particularly in those with an increased waist to hip ratio \[[@CR39], [@CR40]\]. Patients with a normal 25-OH vitamin D had a significantly lower body mass index than the vitamin insufficient and deficient groups (Table [1](#Tab1){ref-type="table"}). The role of obesity in modulating circulating 25-OH vitamin D concentrations during critical illness and its impact upon clinical outcomes warrants further investigation.

There is an abundant amount of emerging literature that critical illness, per se, is a causative factor in the development of vitamin D insufficiency and deficiency \[[@CR1]--[@CR8], [@CR10], [@CR11], [@CR29], [@CR30], [@CR35]\]. Serum 25-OH vitamin D concentrations have been demonstrated to decrease as early as 3 days post ICU admission and remain depressed for at least 10 days \[[@CR30]\]. Inflammatory stress states, including sepsis, results in decreases in serum vitamin D-binding protein concentration \[[@CR1], [@CR8], [@CR42]\] which ultimately results in a decrease in 25-OH vitamin D concentration. Our population exhibited a high level of stress and inflammation as evidenced by a high ISS and elevated CRP concentrations (Table [1](#Tab1){ref-type="table"}).

The most appropriate time post admission for assessing the presence of vitamin D deficiency for critically ill patients is controversial. Fluid resuscitation may acutely lower 25-OH vitamin D concentration. Serial 25-OH vitamin D concentrations in post cardiopulmonary bypass surgery patients were reduced by 35 % during the procedure but returned to within \~10 % of baseline concentrations within 24 h \[[@CR43]\]. Seventy percent of our 25-OH vitamin D observations were conducted at least 5 days after admission to the ICU, and none were measured any earlier than 2 days post admission as we attempted to avoid obtaining serum concentrations during fluid resuscitation.

It also has been recommended that multiple determinations be performed due to assay variability and possible diurnal variation in 25-OH vitamin D concentrations \[[@CR44]\]. However, the influence of diurnal variation was eliminated in our study as vitamin D concentrations were obtained at about the same time (0100) for all patients. Twenty-four patients had a second 25-OH vitamin D determination several days later (and prior to supplemental vitamin D therapy \[[@CR29]\]) which indicated a clinically irrelevant difference in concentration of \~1 ng/mL. Taken together, these data indicate that the observed high prevalence of vitamin D insufficiency and deficiency for critically ill patients with traumatic injuries, based on serum 25-OH vitamin D concentration, was correctly quantitated.

No statistically significant difference was noted among groups for infection rates; however, it is possible that clinical outcomes in those with vitamin D deficiency may have been confounded by the provision of vitamin D therapy per the current practice of the Nutrition Support Service at our institution (Table [4](#Tab4){ref-type="table"}) \[[@CR29]\]. Patients with a normal 25-OH vitamin D concentration and did not require vitamin D supplementation had a decreased ICU length of stay that approached statistical significance (*P* = 0.053) compared to the other groups (Table [3](#Tab3){ref-type="table"}); however, these data should also be interpreted with caution due to the low number of subjects with a normal serum 25-OH vitamin D concentration. Although numerous studies suggest a relationship between vitamin D deficiency and increased mortality and infectious complications for critically ill patients \[[@CR2]--[@CR8]\], it is still considered controversial and unclear whether a low serum 25-OH vitamin D concentration may be a signal of an activated immune system during the acute phase of critical illness rather than a risk factor for impaired immunity or survival \[[@CR32], [@CR35]\]. It also has been suggested that it is not entirely clear if a poor vitamin D status is more of an indicator of an unhealthy lifestyle, multiple risk factors for morbidity, and consequently associated with poorer prognostic outcomes \[[@CR45]\].

This study has limitations. This study was performed at a single medical center and lacks a comparative normal healthy control group from our region of the country. Pre-morbid vitamin D concentrations for the patients were not available. The assay for vitamin D-binding protein was unavailable at our institution which could have provided further insight into the amount of bioavailable vitamin D with each group. However, lack of vitamin D-binding protein concentrations will not alter the interpretation of these data as 25-OH vitamin D and binding protein concentrations tend to parallel each other \[[@CR14], [@CR36]\]. The timing of the initial and subsequent 25-OH vitamin D assays post admission to the ICU was allowed to be within a target range of about 2 weeks post admission (excluding the immediate resuscitation period) and not precisely standardized by day of ICU admission among groups. A greater number of patients with a normal 25-OH vitamin D concentration would have been more meaningful for comparative group evaluations. Finally, comparison of clinical outcomes for the depleted and severely depleted patient groups were likely skewed by the administration of supplemental vitamin D therapy. A separate analysis of groups without provision of vitamin D supplementation is warranted for examining the extent of vitamin D depletion upon clinical outcomes.

Conclusions {#Sec12}
===========

The majority of critically ill patients with traumatic injuries, particularly those with penetrating wounds, and those with obesity or of African-American race are at greater risk for deficiency. Severity of injury, extent of inflammation, or hospital admission during the winter season did not significantly influence the prevalence of vitamin D deficiency. Whether vitamin D supplementation will improve clinical outcomes for this population requires further research.
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